Professional Documents
Culture Documents
MEDICIN
FASCICULA XVII, no 1, 2012
ORIGINAL STUDY
ELECTROCHEMICAL DETERMINATION OF CATECHIN IN
PHARMACEUTICAL DOSAGE FORMS
I.M. Apetrei1,*, D. Tutunaru1, M.L. Rodriguez-Mendez2
1
irina_apetrei@yahoo.com
ABSTRACT
A novel biosensor based on screen-printed technology was constructed, characterized and used to
evaluate catechin in pharmaceutical dosage forms. The biosensor performances were analyzed by
chronoamperometry in model solution of catechin. The amperometric studies show an intense cathodic peak
depending catechin concentration. The cathodic peak was attributed to the reduction of enzymatically produced
o-quinone at the biosensor surface. The optimal conditions for biosensor were founded. In optimal conditions,
the kinetics of the enzymatic reaction fitted into a MichaelisMenten type kinetics, as confirmed by the h
performances of the biosensor. Pharmaceutical samples were analyzed with biosensor to evaluate its real
feasibility in pharmaceutical analysis.
KEYWORDS: biosensor, tyrosinase, pharmaceutical analysis
1. Introduction
the sensor.
53
FASCICULA XVII
and
surface.
high-performance
liquid
chromatography
The
enzyme,
tyrosinase
(Tyr),
was
economic.
Numerous
amperometric
biosensors
of
polyphenolic
compounds
for
were
developed [17-22].
process.
The
enzyme-immobilized
biosensor
was
in aqueous solutions.
Electrochemical measurements
Electrochemical
analytical
preformed
characteristics
of
the
using
measurements
an
EG&G,
Model
were
263
was studied.
fabricated at the Dropsens, Spain, using screenprinting technology. They have graphite working
electrodes with an area of about 4 mm2 [23]. All
Pharmaceutical analysis
used
purification.
and
without
any additional
54
FASCICULA XVII
concentrations
was
found
to
be
insignificant
electrodes.
As a result of enzymatic activity, catechin is
oxidized to catechin-orthoquinone which is reduced
amperometrically at -0.080 V (vs. Ag/AgCl).
Figure 3 shows the amperometric response for
the biosensor at -0.080 V after the addition of
successive aliquots of catechin to the 0.01 M PBS
(pH 7.0) under constant stirring. The resulting
reduction current is directly proportional to the
concentration of catechin present in the solution,
which results from the electrochemical reduction of
hydroxylation
of
monophenols
to
o-
scheme
of
the
enzymatic
and
55
FASCICULA XVII
56
FASCICULA XVII
Pharmaceutical product
Green Tea
Mega Green
Extract
Tea
70
338
epigallocatechin gallate)
64
330
2.14
5.56
4. Conclusions
K Mapp
1
1
I I max I max S
transfer
between
the
enzymatically-produced
Acknowledgments
Pharmaceutical studies
This work has benefited from financial support through the 2010
with biosensor
to
evaluate
its real
INTEREST
feasibility.
POSTDOCTORAL
BIOTECHNOLOGIES
WITH
SCHOOL
IMPACT
OF
ON
APPLIED
ROMANIAN
Development 2007-2013.
References
57
FASCICULA XVII
58